Benzimidazol-2-one derivatives and their use
Certain 1,5-disubstituted benzimidazol-2-one compounds useful as therapeutic agents. The compounds may be of the Formula I wherein: R′ represents hydrogen or alkyl; R″ represents halogen or trihalogenmethyl; and Hlg represents halogen; provided, however, that if Hlg is F, then R″ is not Cl. Also, use of the 1,5-disubstituted benzimidazol-2-one compounds, or pharmaceutically-acceptable addition salts thereof, in applications that benefit from increasing the blood-brain barrier permeability.
1. A 1,5-disubstituted benzimidazol-2-one compound which is
1-(5-chloro-2-hydroxyphenyl)-5-chloro-1,3 -dihydro-2H-benzimidazo-2-one;
or a pharmaceutically-acceptable salt thereof.
2. A pharmaceutical composition comprising a therapeutically effective amount of the 1,5-disubstituted benzimidazol-2-one compound of claim 1 , or a pharmaceutically-acceptable addition salt thereof, together with at least one pharmaceutically-acceptable carrier or diluent.
3. The pharmaceutical composition of claim 2 , which composition also comprises a chemotherapeutic agent.
4. A method of increasing the blood-brain barrier permeability a mammal, including a human, which method comprises the step of administering to such a living animal body in need thereof, a therapeutically effective amount of a 1,5-disubstituted benzimidazol-2-one compound of claim 1 , or a pharmaceutically-acceptable salt thereof.
5. The method according to claim 4 , which method comprises co-administration of a chemotherapeutic agent.
6. A kit-of-parts useful for enhancing the delivery of a medicament to the brain, which kit comprises:
the 1,5-disubstituted benzimidazol-2-one compound of claim 1 ;
a chemotherapeutic agent; and
instructions for using the 1,5-disubstituted benzimidazol-2-one compound for enhancing delivery of the chemotherapeutic agent to the brain.